US 8580768
Cannabinoid receptor antagonists-inverse agonists useful for treating metabolic disorders, including obesity and diabetes
granted A61KA61K9/0019A61K9/2018
Quick answer
US patent 8580768 (Cannabinoid receptor antagonists-inverse agonists useful for treating metabolic disorders, including obesity and diabetes) held by Jenrin Discovery, LLC expires Mon Nov 07 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Jenrin Discovery, LLC
- Grant date
- Tue Nov 12 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 07 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61K, A61K9/0019, A61K9/2018, A61K9/2059, A61K9/4866